📰 Relapsing Forms News
Relapsing Forms News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Relapsing Forms. Real-time updates on events, politics, business and more.
August 25, 2023
Polpharma Biologics Announces FDA Approval of Tyruko® -  First And Only Approved Biosimilar to Tysabri®* for Relapsing Forms of Multiple SclerosisAMSTERDAM, The Netherlands, August 25, 2023 / B3C newswire / -- Polpharma Biologics, an international biotech company dedicated to the development and ma...
April 24, 2023
/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, and Mapi Pharma today announced that recent data from ongoing studies of GA Depot 40...
March 13, 2023
/PRNewswire/ -- Accord Healthcare, Inc., a leading generic pharmaceutical company, has added Teriflunomide to its portfolio of oral medications. The drug is...
March 7, 2023
The long-acting glatiramer acetate therapy GA Depot was found to ease disability in patients with relapsing forms of MS in a Phase 3 trial.
October 12, 2022
GA Depot is a Potential Long Acting Injection Solution for Multiple Sclerosis Patients Positive Results from Phase III GA Depot Study in Relapsing MS to...
February 22, 2022
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that 13 company-sponsored data presentations from its multiple...
October 13, 2021
Early treatment in multiple sclerosis (MS) with higher-potency therapies can improve long-term patient outcomes1,2 New subgroup analysis of the pivotal Phase 3 OPTIMUM trial shows that MS patients